Zenas BioPharma, Inc. Proceeds from Issuance of Debt
Zenas BioPharma, Inc. (ZBIO) reported Proceeds from Issuance of Debt of $75.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-03-16
- Zenas BioPharma, Inc. proceeds from issuance of debt for the quarter ending 2025-12-31 was $0.00.
- Zenas BioPharma, Inc. proceeds from issuance of debt for fiscal 2025 was $75.00M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $75.00M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $75.00M 10-Q · filed 2025-11-12 |